Rose Nabatanzi

871 total citations
22 papers, 329 citations indexed

About

Rose Nabatanzi is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Rose Nabatanzi has authored 22 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 12 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Rose Nabatanzi's work include HIV Research and Treatment (12 papers), Immune Cell Function and Interaction (6 papers) and Cytomegalovirus and herpesvirus research (5 papers). Rose Nabatanzi is often cited by papers focused on HIV Research and Treatment (12 papers), Immune Cell Function and Interaction (6 papers) and Cytomegalovirus and herpesvirus research (5 papers). Rose Nabatanzi collaborates with scholars based in Uganda, United States and United Kingdom. Rose Nabatanzi's co-authors include Damalie Nakanjako, Moses Joloba, Harriet Mayanja‐Kizza, Agnes Kiragga, Moses R. Kamya, Stephen Cose, Lois Bayigga, Huyen Cao, Isaac Ssewanyana and Robert Colebunders and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Rose Nabatanzi

20 papers receiving 328 citations

Peers

Rose Nabatanzi
Louis Evans United Kingdom
Maddalena Cerrone United Kingdom
Madeleine Rothen Switzerland
Maged P. Ghali United States
Routy Jp Canada
Tristan I. Evans United States
Rose Nabatanzi
Citations per year, relative to Rose Nabatanzi Rose Nabatanzi (= 1×) peers Ravinder Kaur Sachdeva

Countries citing papers authored by Rose Nabatanzi

Since Specialization
Citations

This map shows the geographic impact of Rose Nabatanzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose Nabatanzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose Nabatanzi more than expected).

Fields of papers citing papers by Rose Nabatanzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rose Nabatanzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose Nabatanzi. The network helps show where Rose Nabatanzi may publish in the future.

Co-authorship network of co-authors of Rose Nabatanzi

This figure shows the co-authorship network connecting the top 25 collaborators of Rose Nabatanzi. A scholar is included among the top collaborators of Rose Nabatanzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rose Nabatanzi. Rose Nabatanzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bongomin, Felix, Joseph Baruch Baluku, Rose Nabatanzi, et al.. (2025). Bacille Calmette-Guérin-specific IgG titres among infants born to mothers with active tuberculosis disease in Uganda. BMC Immunology. 26(1). 13–13.
2.
Nabatanzi, Rose, Gyaviira Nkurunungi, Davis Kibirige, et al.. (2025). Metabolic dysfunction impairs Mycobacterium tuberculosis-specific cytokine and chemokine responses in latent tuberculosis and type 2 diabetes mellitus. Scientific Reports. 15(1). 30474–30474.
3.
Nabatanzi, Rose, Bernard S. Bagaya, Davis Kibirige, et al.. (2024). Impaired Mycobacterium tuberculosis-specific T-cell memory phenotypes and functional profiles among adults with type 2 diabetes mellitus in Uganda. Frontiers in Immunology. 15. 1480739–1480739. 2 indexed citations
4.
Nakanjako, Damalie, Rose Nabatanzi, Isaac Ssinabulya, et al.. (2024). Chronic immune activation and accelerated immune aging among HIV-infected adults receiving suppressive antiretroviral therapy for at least 12 years in an African cohort. Heliyon. 10(11). e31910–e31910. 3 indexed citations
6.
Nabatanzi, Rose, Moses Egesa, Matthew R. Hepworth, et al.. (2021). Type 2 Diabetes Mellitus and Latent Tuberculosis Infection Moderately Influence Innate Lymphoid Cell Immune Responses in Uganda. Frontiers in Immunology. 12. 716819–716819. 13 indexed citations
7.
Seremba, Emmanuel, Ponsiano Ocama, Richard Ssekitoleko, et al.. (2021). Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda. Vaccine. 39(8). 1265–1271. 6 indexed citations
8.
Nabatanzi, Rose, Lois Bayigga, Stephen Cose, et al.. (2021). Innate lymphoid cell dysfunction during long-term suppressive antiretroviral therapy in an African cohort. BMC Immunology. 22(1). 59–59. 8 indexed citations
9.
Kwizera, Richard, et al.. (2021). Translational research in Uganda: linking basic science to bedside medicine in a resource limited setting. Journal of Translational Medicine. 19(1). 76–76. 5 indexed citations
12.
Nabatanzi, Rose, Lois Bayigga, Stephen Cose, et al.. (2019). Aberrant natural killer (NK) cell activation and dysfunction among ART-treated HIV-infected adults in an African cohort. Clinical Immunology. 201. 55–60. 32 indexed citations
13.
Nabatanzi, Rose, et al.. (2018). Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells. AIDS Research and Therapy. 15(1). 7–7. 36 indexed citations
14.
Nakanjako, Damalie, Isaac Ssewanyana, Rose Nabatanzi, et al.. (2014). CD4 T-cell activation and reduced regulatory T-cell populations are associated with early development of cataracts among HIV-infected adults in Uganda. Immunology Letters. 161(1). 44–49. 9 indexed citations
15.
Nabatanzi, Rose, Lois Bayigga, Isaac Ssinabulya, et al.. (2014). Low antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohort. Immunology Letters. 162(2). 264–272. 8 indexed citations
16.
Nakanjako, Damalie, Isaac Ssinabulya, Rose Nabatanzi, et al.. (2014). Atorvastatin reduces T‐cell activation and exhaustion among HIV‐infected cART‐treated suboptimal immune responders in Uganda: a randomised crossover placebo‐controlled trial. Tropical Medicine & International Health. 20(3). 380–390. 39 indexed citations
18.
Nakanjako, Damalie, Isaac Ssewanyana, Rose Nabatanzi, et al.. (2013). Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort. BMC Immunology. 14(1). 26–26. 15 indexed citations
19.
Cattamanchi, Adithya, Rose Nabatanzi, Cecily Miller, et al.. (2012). Bronchoalveolar Lavage Enzyme-Linked Immunospot for Diagnosis of Smear-Negative Tuberculosis in HIV-Infected Patients. PLoS ONE. 7(6). e39838–e39838. 17 indexed citations
20.
Nakanjako, Damalie, Isaac Ssewanyana, Harriet Mayanja‐Kizza, et al.. (2011). High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort. BMC Infectious Diseases. 11(1). 43–43. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026